Continue reading “A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis”
Tag: drug
Opinion: Burdensome Medicare GLP-1 Program May Keep Patients from Accessing $50 Per
MBNL1 Identified as a Potential Cancer Drug Target for a Type
How a Veterans Affairs Study Can Help Guide Prostate Cancer Treatment
Biomarkers Aid Cost-benefit Analysis of Head and Neck Cancer Immunotherapy
Study Reveals Growing Signs of Malaria Drug Resistance in Ethiopia
Real-world Study Provides New Insights into Safety of New Alzheimer’s Drug Lecanemab
Study Suggests Experimental Drug Dismantles 2 Key Proteins that Help Tumors Survive
Rare Human Brain Study Reveals How an Alzheimer’s Drug May Protect
STAT+: Pharmalittle: We’re Reading About Replimune’s Melanoma Drug
Protective Drug Dexrazoxane Reduces Heart Damage in Pediatric Cancer Survivors Years After
Oral Weight Loss Pill Helps Patients Lose up to 12% of Body
Vitamin C May Fight Cancer — But Not the Way Scientists Once
Stopping ADHD Medication Alters Sleep Rhythms Long After Discontinuation
STAT+: Medicare Quietly Gave Blockbuster AbbVie Drug Seven Extra Years Before Price
STAT+: Study Reveals New Role for Tau
Wearable Electric-field Device Slows Aggressive Breast Cancer in Preclinical Study
‘It Can Make You Psychotic or Give You a Cardiac Arrest’: Why
FDA Approves Moderna’s mRNA Flu Vaccine
Systemic Gap in Drug Subsidies Leaves Low-income Pregnant Women with Fewer Treatment
A New Drug that Can Potentially Overcome Cancer Therapy Resistance
GLP-1 Drug Linked to Heart Benefits for High-risk Patients
First-in-class Small Molecule Inhibitor Shows Promise Against Pancreatic Cancer in Preclinical Studies
New Therapy Shrinks Tumors to Treat Lung Cancer
ChuckysCarnage 